(Q22241918)

Prognostic implication of creatine kinase elevation following elective coronary artery interventions.

PubMed

volume

3

0 references

issue

6

0 references

page(s)

602-610

0 references

cites work

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Prognostic value of cardiac troponin I elevation after percutaneous coronary intervention in patients with chronic renal insufficiency: a 12-month outcome analysis

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Prognostic value of troponin after elective percutaneous coronary intervention: A meta-analysis

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

In-hospital and nine-month outcomes among patients with coronary lesions involving a side branch and treated with bare metal stents

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Microvascular reactivity after crystalloid, cold blood, and warm blood cardioplegic arrest

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Preprocedural plasma C-reactive protein levels, postprocedural creatine kinase-MB release, and long-term prognosis after successful coronary stenting (four-year results from the GENERATION study).

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Visualisation and quantification of peri-operative myocardial infarction after coronary artery bypass surgery with contrast-enhanced magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Platelet-monocyte aggregates predict troponin rise after percutaneous coronary intervention and are inhibited by Abciximab

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

The quantification of infarct size

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Interven

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Prognostic implication of creatine kinase release after elective percutaneous coronary intervention in the pre-IIb/IIIa antagonist era.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Preprocedural white blood cell count and death after percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Relation between coronary atherosclerotic plaque burden and cardiac enzyme elevation following percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Prognostic value of cardiac troponin I re-elevation following percutaneous coronary intervention in high-risk patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Association of systemic inflammatory state with troponin I elevation after elective uncomplicated percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Prognostic implication of troponin I elevation after percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Frequency and prognostic value of cardiac troponin I elevation after coronary stenting

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Endothelin-1 release from atherosclerotic plaque after percutaneous transluminal coronary angioplasty in stable angina pectoris and single-vessel coronary artery disease

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Intracoronary serotonin release after high-pressure coronary stenting

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Assessment of coagulation and platelet activation in coronary sinus blood induced by transcatheter coronary intervention for narrowing of the left anterior descending coronary artery

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Differentiation between transmural perioperative myocardial infarction and subendocardial injury after coronary artery bypass grafting using biochemical tests, elaborated by cluster and discriminant analysis

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Release of cardiac troponin in acute coronary syndromes: ischemia or necrosis?

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Prognostic significance of elevated creatine kinase MB after coronary bypass surgery and after an acute coronary syndrome: results from the GUARDIAN trial.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

The GP IIb/IIIa inhibitor abciximab (c7E3) inhibits the binding of various ligands to the leukocyte integrin Mac-1 (CD11b/CD18, alphaMbeta2).

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Prognostic significance of elevated troponin I after percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Graft patency in patients with coronary artery bypass operation complicated by perioperative myocardial infarction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Frequency and long-term impact of myonecrosis after coronary stenting

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Prasugrel versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Bivalirudin during primary PCI in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Troponin I elevation and cardiac events after percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

The white blood cell count is an independent predictor of no-reflow and mortality following acute myocardial infarction in the coronary interventional era.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

The Lescol ® Intervention Prevention Study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Peri-procedural myocardial injury: 2005 update

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Baseline troponin level: key to understanding the importance of post-PCI troponin elevations

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Relation of inflammation and benefit of statins after percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Troponin Elevation After Percutaneous Coronary Intervention Directly Represents the Extent of Irreversible Myocardial Injury

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Clinical and angiographic predictors of short- and long-term ischemic events in acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Cardiac enzyme elevation after successful percutaneous coronary intervention is not an independent predictor of adverse outcomes.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Redefinition of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in My

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021

Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCINTERVENTIONS.110.959080

7 January 2021